VENABLE LLP for ENDO PHARMACEUTICALS INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life sciences research; tax treatment of inverted companies; tax issues in mergers and acquisitions of US firms.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act; issues relating to patent settlements; patent reform; issues relating to misuse of the inter pares review process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Health Issues HCR
Issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant formulations; issues relating to FDA approvals of new drugs and generic drugs; issues related to the FDA; issues related to Opioids; issues relating to Medicare Part D rebates; Issues relating to the labeling of generic drugs; issues relating to CDC guidance for prescribing opioids; Issues relating to products containing high doses of acetaminophen; issues relating to the labeling of generic drugs; issues relating to removal of FDA unapproved products from the market;- Opioid abuse legislation; issues relating to prescription drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.